Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 3 minute read Metals and Mining Industry News Gold surprise and copper clues: Regener8 Resources doubles down on North Achilles amid shifting stock sentiment Regener8 Resources shifts focus to North Achilles after East Ponton drill results. See latest stock trends, sentiment, and what's next for ASX: R8R. byPallavi MadhirajuApril 20, 2025